Rohmad Yudi Utomo

12PUBLICATIONS
20CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 22, 2026
Comprehensive Molecular Docking and Molecular Dynamics Reveal Inhibitors of HER2 L755S, T798I, and T798M based on a Large Database of Curcumin Derivatives.

Mantiqa Syafa Duvadillan Gusrin, Yonika Arum Larasati, Rohmad Yudi Utomo

|Aug 01, 2025
Effect of PGV-1 on Apoptosis via Mitotic Arrest and Senescence in Polyploid Giant Cancer Cells of Hepatocellular Carcinoma JHH4.

Nadzifa Nugraheni, Beni Lestari, Edy Meiyanto

|Jul 19, 2025
Discovery of pyroptosis-inducing natural products in neuroblastomas: computational studies with experimental validation.

Beni Lestari, Rohmad Yudi Utomo, Faaza Aulia Rahman

|Nov 04, 2024
PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status.

Nadzifa Nugraheni, Ummi Maryam Zulfin, Beni Lestari

|Aug 29, 2022
Synergistic Cytotoxic and Antimigratory Effect of Brazilein and Doxorubicin on HER2-Overexpressing Cells.

Sri Handayani, Ratna Asmah Susidarti, Rohmad Yudi Utomo

|Aug 08, 2022
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties.

Rohmad Yudi Utomo, Febri Wulandari, Dhania Novitasari

Pageof 2

Frequent Collaborators

9 joint publications

Edy Meiyanto

6 joint publications

Riris Istighfari Jenie

6 joint publications

Beni Lestari

3 joint publications

Dhania Novitasari